Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selective Lymph Node Dissection Using ICG in Breast Cancer
NCT02781259Phase 4Unknown
- Sponsor
- Samsung Medical Center
- Start
- May 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of indocyanine green in breast cancer, sponsored by Samsung Medical Center. Primary endpoint: Number of metastatic lymph nodes in fluorescent positive and negative lymph nodes at 2 weeks. Status: unknown.
02
Drugs
indocyanine green
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02781259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02781259.